Anika Therapeutics, Inc. - ANIK

About Gravity Analytica
Recent News
- 06.05.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 05.12.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 05.09.2025 - Anika Reports First Quarter 2025 Financial Results
- 05.07.2025 - Anika to Participate in the Sidoti Virtual Investor Conference
- 04.25.2025 - Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
- 04.07.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 04.01.2025 - Hydration and Joint Health: Why Water is Your Best Friend
Recent Filings
- 05.09.2025 - 8-K Current report
- 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 05.09.2025 - EX-99.1 EX-99.1
- 04.28.2025 - ARS Annual Report to Security Holders
- 04.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 04.28.2025 - DEF 14A Other definitive proxy statements
- 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 04.11.2025 - 3 Initial statement of beneficial ownership of securities
- 04.10.2025 - 8-K Current report
- 03.18.2025 - 4 Statement of changes in beneficial ownership of securities